Surgical bioprosthesis true ID and fracture impact on gradients after valve-in-valve TAVI
Valve-in-valve (ViV) transcatheter aortic valve implantation (TAVI) is the preferred therapy for degenerated surgical bioprostheses, yet residual gradients, patient–prosthesis mismatch (PPM), and coronary obstruction remain major concerns. This study aims to assess procedural safety and mid-to-long term ou...